-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Actinium Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Actinium Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.03M, a 3.91% decline year-over-year.
- Actinium Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $4.04M, a 48.3% increase year-over-year.
- Actinium Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $3.1M, a 185% increase from 2022.
- Actinium Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $1.09M, a 472% increase from 2021.
- Actinium Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $190K, a 6.74% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)